Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Radiation × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 28 Glioblastoma 26 Breast Neoplasms 19 Lung Neoplasms 18 Carcinoma, Non-Small-Cell Lung 14 Oropharyngeal Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Gliosarcoma 9 Brain Neoplasms 9 Uterine Cervical Neoplasms 8 Urinary Bladder Neoplasms 8 Sarcoma 7 Melanoma 7 Esophageal Neoplasms 7 Astrocytoma 7 Triple Negative Breast Neoplasms 6 Mouth Neoplasms 6 Head and Neck Neoplasms 6 Glioma 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Squamous Cell 5 Adenocarcinoma Of Esophagus 5 Neoplasms 4 Laryngeal Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Adenocarcinoma of Lung 4

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡